CHMP recommends VeraSeal for use as a sealant during surgical operations in adults,- Instituto Grifols.
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product VeraSeal, intended for use as a sealant during surgical operations in adults. The applicant for this medicinal product is Instituto Grifols, S.A.
This product was withdrawn from EMA on 29 September 2015.
Comment: The benefits of VeraSeal are its ability to help the wound to heal and prevention of bleeding. The most common side effects are procedural pain, nausea, pruritus and pyrexia.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins